ALB and gastric cancer: NLR/Alb, as a combined immune status and nutritional index, can minimize the potential bias related to the nutritional and immune statuses of patients with cancer.5 Although it has been reported as a prognostic factor for gastric cancer after curative resection,5 there are no reports yet regarding its use in the prognostic prediction of patients with terminal gastric cancer receiving end-of-life care.